Dunhill Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267 | Sell |
1
-12
| -92% | -$3.2K | ﹤0.01% | 920 |
|
|
2025
Q1 | $1.97K | Sell |
13
-1
| -7% | -$152 | ﹤0.01% | 734 |
|
|
2024
Q4 | $2.59K | Buy |
14
+3
| +27% | +$555 | ﹤0.01% | 670 |
|
|
2024
Q3 | $2.23K | Buy |
11
+6
| +120% | +$1.21K | ﹤0.01% | 696 |
|
|
2024
Q2 | $1.11K | Buy |
5
+1
| +25% | +$222 | ﹤0.01% | 668 |
|
|
2024
Q1 | $1.16K | Hold |
4
| – | – | ﹤0.01% | 612 |
|
|
2023
Q4 | $856 | Buy |
+4
| New | +$856 | ﹤0.01% | 625 |
|